GLP-1 Receptor Agonist Randomized Trial: Efficacy & Safety
Comments Off on GLP-1 Receptor Agonist Randomized Trial: Efficacy & Safety
May 11, 2026
GLP-1 Clinical Relevance #36Contextual Information Background context; limited direct clinical applicability. ⚕ GLP-1 News | CED Clinic Clinical NewsPolicy ImplementationObesity ManagementSemaglutidePrimary CareMedicare…
The Pulse: More Virginians Opt for Bronze Health Plans Amid Premium Rise
Comments Off on The Pulse: More Virginians Opt for Bronze Health Plans Amid Premium Rise
March 26, 2026
Health insurance tier selection directly impacts patient access to cannabis medicine, especially as more Virginians opt for Bronze health plans. These plans often have higher deductibles and restrictive formularies, creating barriers for patients.…
Missouri’s $100 Million Marijuana Tax Revenue Sits Unused Despite Voter Mandate
Comments Off on Missouri’s $100 Million Marijuana Tax Revenue Sits Unused Despite Voter Mandate
March 23, 2026
Missouri’s marijuana tax revenue allocation remains delayed, leaving nearly $100 million unused despite voter mandates. This delay impacts healthcare access and substance abuse treatment programs dependent on these funds. Understanding marijuana tax…